V004-0435 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(4-butylphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(furan-2-yl)methyl]acetamide

V004-0435 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(4-butylphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(furan-2-yl)methyl]acetamide
V004-0435 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(4-butylphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(furan-2-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V004-0435
N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(4-butylphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(furan-2-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V004-0435

Molecular Formula

C32H39N3O6 (C32 H39 N3 O6)

Compound Name

N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-[1-(4-butylphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(furan-2-yl)methyl]acetamide

IUPAC name

N-[(2H-13-benzodioxol-5-yl)methyl]-2-[1-(4-butylphenyl)-N-[2-(morpholin-4-yl)ethyl]formamido]-N-[(furan-2-yl)methyl]acetamide

SMILES

CCCCc(cc1)ccc1C(N(CCN1CCOCC1)CC(N(Cc1ccco1)Cc(cc1)cc2c1OCO2)=O)=O

InChI

InChI=1S/C32H39N3O6/c1-2-3-5-25-7-10-27(11-8-25)32(37)34(14-13-33-15-18-38-19-16-33)23-31(36)35(22-28-6-4-17-39-28)21-26-9-12-29-30(20-26)41-24-40-29/h4,6-12,17,20H,2-3,5,13-16,18-19,21-24H2,1H3

InChI Key

CMHBDTKCFJDYCS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19744485

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

561.68

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

15.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.320

Distribution Coefficient, logD

4.315

Water Solubility, LogSw

-4.14

Polar Surface Area

68.595

Acid Dissociation Constant (pKa)

21.89

Base Dissociation Constant (pKb)

5.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.80

V004-0435 in Drug Discovery

Included in Screening Libraries

SH2 Library (10483 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Endocrine
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with V004-0435 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V004-0435?
Check Price and Availability of V004-0435, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V004-0435 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V004-0435
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V004-0435
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V004-0435 available by request